159 related articles for article (PubMed ID: 30406970)
1. Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma.
Yang M; Yang C; Tao Y; Tang J; Huang Q; Guo W; Feng S; Jiang A; Xu X; Jiang G; Liu Y
Cancer Med; 2018 Dec; 7(12):5928-5942. PubMed ID: 30406970
[TBL] [Abstract][Full Text] [Related]
2. Enhanced antitumor efficacy of a novel oncolytic adenovirus combined with temozolomide in the treatment of melanoma in vivo.
Jiang G; Sun C; Li RH; Wei ZP; Zheng JN; Liu YQ
J Cancer Res Clin Oncol; 2015 Jan; 141(1):75-85. PubMed ID: 25103017
[TBL] [Abstract][Full Text] [Related]
3. A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis.
Jiang G; Jiang AJ; Cheng Q; Tian H; Li LT; Zheng JN
Tumour Biol; 2013 Apr; 34(2):1263-71. PubMed ID: 23430584
[TBL] [Abstract][Full Text] [Related]
4. A conditionally replicating adenovirus expressing IL-24 acts synergistically with temozolomide to enhance apoptosis in melanoma cells
Liang Z; Yang CS; Gu F; Zhang LS
Oncol Lett; 2017 Jun; 13(6):4185-4189. PubMed ID: 28599419
[TBL] [Abstract][Full Text] [Related]
5. Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.
Jiang G; Yang CS; Xu D; Sun C; Zheng JN; Lei TC; Liu YQ
Br J Cancer; 2014 May; 110(10):2496-505. PubMed ID: 24714752
[TBL] [Abstract][Full Text] [Related]
6. The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer.
Zhao L; Dong A; Gu J; Liu Z; Zhang Y; Zhang W; Wang Y; He L; Qian C; Qian Q; Liu X
Cancer Gene Ther; 2006 Nov; 13(11):1011-22. PubMed ID: 16799468
[TBL] [Abstract][Full Text] [Related]
7. Selective effects of a fiber chimeric conditionally replicative adenovirus armed with hep27 gene on renal cancer cell.
Fang L; Cheng Q; Liu W; Zhang J; Ge Y; Zhang Q; Li L; Liu J; Zheng J
Cancer Biol Ther; 2016 Jun; 17(6):664-73. PubMed ID: 27195521
[TBL] [Abstract][Full Text] [Related]
8. Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.
Zhao L; Gu J; Dong A; Zhang Y; Zhong L; He L; Wang Y; Zhang J; Zhang Z; Huiwang J; Qian Q; Qian C; Liu X
Hum Gene Ther; 2005 Jul; 16(7):845-58. PubMed ID: 16000066
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms of enhanced antileukemia activity of conditionally replicating adenovirus (CRAd) ZD55 by interleukin-24].
Liu JQ; Yang CM; Ding W; Qian WB
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 May; 39(3):231-5. PubMed ID: 20544982
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
Qian W; Liu J; Tong Y; Yan S; Yang C; Yang M; Liu X
Leukemia; 2008 Feb; 22(2):361-9. PubMed ID: 18046450
[TBL] [Abstract][Full Text] [Related]
11. Development of an optimized conditionally replicative adenoviral agent for ovarian cancer.
Zhu ZB; Lu B; Park M; Makhija SK; Numnum TM; Kendrick JE; Wang M; Tsuruta Y; Fisher P; Alvarez RD; Zhou F; Siegal GP; Wu H; Curiel DT
Int J Oncol; 2008 Jun; 32(6):1179-88. PubMed ID: 18497979
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic adenovirus expressing interleukin-18 induces significant antitumor effects against melanoma in mice through inhibition of angiogenesis.
Zheng JN; Pei DS; Mao LJ; Liu XY; Sun FH; Zhang BF; Liu YQ; Liu JJ; Li W; Han D
Cancer Gene Ther; 2010 Jan; 17(1):28-36. PubMed ID: 19498459
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma.
Yang C; Cao H; Liu N; Xu K; Ding M; Mao LJ
Drug Des Devel Ther; 2016; 10():3755-3761. PubMed ID: 27895465
[TBL] [Abstract][Full Text] [Related]
14. Efficient antitumor effects of carrier cells loaded with a fiber-substituted conditionally replicating adenovirus on CAR-negative tumor cells.
Iguchi K; Sakurai F; Tomita K; Katayama K; Yamaguchi T; Kawabata K; Tagawa M; Kawabata M; Shirakawa T; Mizuguchi H
Cancer Gene Ther; 2012 Feb; 19(2):118-25. PubMed ID: 22076042
[TBL] [Abstract][Full Text] [Related]
15. Potent antitumor efficacy of interleukin-18 delivered by conditionally replicative adenovirus vector in renal cell carcinoma-bearing nude mice via inhibition of angiogenesis.
Zheng JN; Pei DS; Sun FH; Liu XY; Mao LJ; Zhang BF; Wen RM; Xu W; Shi Z; Liu JJ; Li W
Cancer Biol Ther; 2009 Apr; 8(7):599-606. PubMed ID: 19305163
[TBL] [Abstract][Full Text] [Related]
16. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.
Jiang G; Liu YQ; Wei ZP; Pei DS; Mao LJ; Zheng JN
Cancer Lett; 2010 Aug; 294(2):220-8. PubMed ID: 20189296
[TBL] [Abstract][Full Text] [Related]
17. Effective gene-viral therapy of leukemia by a new fiber chimeric oncolytic adenovirus expressing TRAIL: in vitro and in vivo evaluation.
Jin J; Liu H; Yang C; Li G; Liu X; Qian Q; Qian W
Mol Cancer Ther; 2009 May; 8(5):1387-97. PubMed ID: 19417152
[TBL] [Abstract][Full Text] [Related]
18. An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer.
Zhong S; Yu D; Wang Y; Qiu S; Wu S; Liu XY
Acta Oncol; 2010; 49(1):91-9. PubMed ID: 19734998
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effect of TRAIL and IL-24 with complete eradication of hepatoma in the CTGVT-DG strategy.
Cai Y; Liu X; Huang W; Zhang K; Liu XY
Acta Biochim Biophys Sin (Shanghai); 2012 Jun; 44(6):535-43. PubMed ID: 22635106
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated FKHRL1/TM sensitizes melanoma cells to apoptosis induced by temozolomide.
Egger ME; McNally LR; Nitz J; McMasters KM; Gomez-Gutierrez JG
Hum Gene Ther Clin Dev; 2014 Sep; 25(3):186-95. PubMed ID: 25238278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
